167 related articles for article (PubMed ID: 2021942)
21. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
[TBL] [Abstract][Full Text] [Related]
22. Quantitating the frequency of initiation and cH-ras mutation in in situ N-methyl-N-nitrosourea-exposed rat mammary gland.
Zhang R; Haag JD; Gould MN
Cell Growth Differ; 1991 Jan; 2(1):1-6. PubMed ID: 2007094
[TBL] [Abstract][Full Text] [Related]
23. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
[TBL] [Abstract][Full Text] [Related]
24. H-ras induced transformation of mammary epithelium is favoured by increased oncogene expression or by inhibition of mammary regression.
Andres AC; Bchini O; Schubaur B; Dolder B; LeMeur M; Gerlinger P
Oncogene; 1991 May; 6(5):771-9. PubMed ID: 2052356
[TBL] [Abstract][Full Text] [Related]
25. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
26. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
27. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
28. Induction of mouse mammary tumours in a transplantation system by the sequential introduction of the myc and ras oncogenes.
Bradbury JM; Sykes H; Edwards PA
Int J Cancer; 1991 Jul; 48(6):908-15. PubMed ID: 1860737
[TBL] [Abstract][Full Text] [Related]
29. Expression of activated M-Ras in a murine mammary epithelial cell line induces epithelial-mesenchymal transition and tumorigenesis.
Ward KR; Zhang KX; Somasiri AM; Roskelley CD; Schrader JW
Oncogene; 2004 Feb; 23(6):1187-96. PubMed ID: 14961075
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4.
Xuan W; Li YJ; Liu G; Ben-David Y; Archer MC
Mol Cancer Res; 2009 Mar; 7(3):433-42. PubMed ID: 19258414
[TBL] [Abstract][Full Text] [Related]
31. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
[TBL] [Abstract][Full Text] [Related]
32. T1, an immunoglobulin superfamily member, is expressed in H-ras-dependent epithelial tumours of mammary cells.
Rössler U; Andres AC; Reichmann E; Schmahl W; Werenskiold AK
Oncogene; 1993 Mar; 8(3):609-17. PubMed ID: 8437844
[TBL] [Abstract][Full Text] [Related]
33. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
[TBL] [Abstract][Full Text] [Related]
34. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Wang B; Soule HD; Miller FR
Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
[TBL] [Abstract][Full Text] [Related]
35. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.
Houck KA; Michalopoulos GK; Strom SC
Oncogene; 1989 Jan; 4(1):19-25. PubMed ID: 2783773
[TBL] [Abstract][Full Text] [Related]
36. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.
Huber BE; Cordingley MG
Oncogene; 1988 Sep; 3(3):245-56. PubMed ID: 3060790
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
38. Oncogene complementation in fetal brain transplants.
Wiestler OD; Aguzzi A; Schneemann M; Eibl R; von Deimling A; Kleihues P
Cancer Res; 1992 Jul; 52(13):3760-7. PubMed ID: 1319831
[TBL] [Abstract][Full Text] [Related]
39. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
[TBL] [Abstract][Full Text] [Related]
40. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
